The potential outcome of Cyp46a1 transcript levels may help drive attention to the brain cholesterol levels before and at the onset of RTT and other MeCP2-linked brain disorders as well as to the link between MeCP2 and expression of the genes involved in cholesterol metabolism (Figure 4). Here, MECP2 is linked to brain disorder.